Company / Shareholders' Equity
ALX ONCOLOGY HOLDINGS INC Shareholders' Equity History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$263.5M
FY2022
5-year range
-$70.6M / $263.5M
FY2020-FY2022
Trend
+473.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +473% YoY in FY2022, a notable deviation from the 2-year average annual change of +218%.
Based on SEC 10-K filings.
$263M in FY2022.
Improved from -$52M to $263M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, shareholders' equity increased 473.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $263.5M | +473.0% |
| FY2021 | -$70.6M | -36.4% |
| FY2020 | -$51.8M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026